Analyst firms · Raymond James · NEO

Raymond James NEO price target and rating history

NeoGenomics Inc. (NEO) · Health Care

Raymond James rates NeoGenomics Inc. (NEO) Mkt Perform with a $24 price target, as of its latest action on May 16, 2023. It has published 4 rating actions on NEO since October 2021, including 2 upgrades and 1 downgrade.

Current rating
Mkt Perform
Price target
$24
Median target, all firms
Too few
Actions on NEO
4

Raymond James price target on NEO

$53$39$2420222023202420252026
Raymond James price target on NEO, each point a stated target, October 2021 to February 2022.

Every Raymond James rating on NEO

How other firms rate NEO

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
BTIGBuy$28Oct 6, 2026
Leerink PartnersOutperform$25Apr 29, 2026

Questions about Raymond James and NEO

What is Raymond James's price target for NEO?
Raymond James's latest stated price target for NeoGenomics Inc. (NEO) is $24, from its action on Feb 24, 2022.
What is Raymond James's rating on NEO?
Raymond James rates NEO Mkt Perform, a neutral rating, as of May 16, 2023.
When did Raymond James last change its view on NEO?
On May 16, 2023, Raymond James downgrades to Mkt Perform from Outperform.

More NEO rating histories

All Raymond James ratingsNEO news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.